25983-76-0

Basic information

• Product Name: 2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol
• Synonyms: 1-(5-Hydroxy-7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone;2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol;Isoevodionol
• CAS NO: 25983-76-0
• Molecular Formula: C₁₄H₁₆O₄
• Molecular Weight: 248.27
• Mol File: 25983-76-0.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol(25983-76-0)
• EPA Substance Registry System: 2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol(25983-76-0)

Safety Data

• Hazardous Substances Data: 25983-76-0(Hazardous Substances Data)

Usage

General Description

2,2-Dimethyl-6-acetyl-7-methoxy-2H-1-benzopyran-5-ol, also known as dihydrocoumarin, is a chemical compound with a complex structure. It is a natural ingredient found in various plants and is commonly used as a fragrance in perfumes and other scented products. Dihydrocoumarin has a sweet and vanilla-like scent, making it a popular choice for adding a warm and comforting aroma to personal care and household products. In addition to its use in the fragrance industry, dihydrocoumarin also has potential medicinal properties, with research suggesting that it may have antioxidant and anti-inflammatory effects. However, further studies are needed to fully understand its potential health benefits.

Upstream product

• 31525-67-4 dimethylacetal of 3-methyl-3-hydroxybutyraldehyde 
• 3602-54-8 4,6-dihydroxy-2-methoxyacetophenone 
• 32550-59-7 6-Acetyl-5-hydroxy-7-methoxy-3,4-dihydro-2,2-dimethyl-2H<1>benzopyran 
• 30403-01-1 1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]ethanone 
• 107-86-8 3,3-dimethyl acrylaldehyde 
• 1019-60-9 2,3-dihydro-5-hydroxy-7-methoxy-2,2-dimethyl-4H-1-benzopyran-4-one 
• 75-36-5 acetyl chloride 
• 108-73-6 3,5-dihydroxyphenol 
• 883-09-0 5,7-dihydroxy-2,2-dimethylchroman-4-one 
• 541-47-9 3-Methylbutenoic acid 
• 65490-09-7 2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone 
• 450336-12-6 2-hydroxy-4-methoxymethoxy-6-prenyloxyacetophenone 
• 450336-14-8 1-(2-hydroxy-6-methoxy-4-(methoxymethoxy)-3-(3-methylbut-2-enyl)phenyl)ethanone 
• 450336-13-7 1-(2,6-dihydroxy-4-(methoxymethoxy)-3-(3-methylbut-2-en-1-yl)phenyl)ethanone 

Downstream Products

• 128031-07-2 1,3-dioxo-1-(5-hydroxy-7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-(2',4'-dimethoxy-phenyl)-propane 
• 119309-05-6 6-O-acetyl-2,2-dimethyl-5-(4'-methoxy-benzoyloxy)-2H-benzopyran 
• 35930-31-5 Alloptaeroxylin methyl ether 
• 143885-75-0 (2E)-1-(5-hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-methoxyphenyl)prop-2-en-1-one 
• 143885-76-1 3-(3,4-dimethoxyphenyl)-1-(5-hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)propenone 
• 41724-53-2 2-hydroxy-6'-methoxy-6'',6''-dimethylchromeno(4',3':2'',3'')chalcone 
• 1034927-74-6 5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydro-8H-pyrano[2,3-f]chromen-4-one 
• 1034927-75-7 5-[(-)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy-methoxy]-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydro-8H-pyrano[2,3-f]chromen-4-one 
• 450336-11-5 (+/-)-5-methoxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydro-8H-pyrano[2,3-f]chromen-4-one 
• 482-07-5 evodione 
• 119309-04-5 5-methoxy-2-(4-methoxyphenyl)-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b’]dipyran-4-one 
• 128595-68-6 racemoflavone dimethyl ether 
• 119309-06-7 1,3-dioxo-1-(5-hydroxy-7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-(4'-methoxyphenyl)-propane 
• 28419-76-3 4-hydroxy-5-methoxy-3-(4-methoxyphenyl)-8,8-dimethyl-2H,8H-1-benzo-<1,2-b:3,4-b'>-dipyran-2-one 

Relevant articles and documents

Total synthesis of isorobustin

The synthesis of isorobustin 1 in four steps from 5-methoxyresorcinol proceeds in an overall yield of 34%. The key step involves the arylation of a 4-hydroxy-2H-l-benzopyran-2-one 6 by 3,4-methylenedioxyphenyllead triacetate 9 in a chemoselective and regioselective manner.

Chromane-like cyclic prenylflavonoids for the medical intervention in neurological disorders

The present invention relates to certain chromane-like cyclic prenylflavonoids, in particular the compounds of formulae (I), (II) and (III) as described and defined herein, for use in the treatment or prevention of a neurological disorder, as well as their use in promoting neuronal differentiation, neurite outgrowth and neuroprotection.

First total synthesis of (±)-elatadihydrochalcone and its derivatives

-